News from Abroad: Lilly Successfully Defends Zyprexa Compound Patent In Australia

Published date28 March 2013
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP
Subject MatterEli Lilly,Generic Drugs,Patents,Pharmaceutical Industry
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT